Isotretinoine Aurobindo

Isotretinoin, the active ingredient in Isotretinoine Aurobindo, is a retinoid presented as an oral formulation for systemic use. It is indicated for the treatment of severe nodular acne that has not responded to conventional therapies. GNH USA supplies Isotretinoine Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotretinoine Aurobindo is a retinoid that targets severe forms of acne and related refractory disease states. - Severe nodular acne: reduces lesion count and promotes clearance in patients unresponsive to conventional therapy. - Recalcitrant acne: improves skin appearance when other systemic agents have failed. - Severe inflammatory acne: decreases sebum production and inflammation, facilitating long‑term disease control.

Isotretinoine Aurobindo may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dry skin and mucous membranes. - Cheilitis (cracked lips). - Xerosis of eyes causing irritation. - Epistaxis (nosebleeds). - Photosensitivity. - Musculoskeletal aches.

Serious or Rare Side Effects: - Teratogenicity leading to severe fetal malformations. - Depression, suicidal ideation, or other psychiatric disturbances. - Inflammatory bowel disease flare or onset. - Pancreatitis. - Severe hypertriglyceridaemia. - Hepatic toxicity with elevated transaminases.

Before initiating therapy, several safety considerations should be observed. - Pregnancy: contraindicated due to high risk of fetal malformations. - Baseline labs: obtain liver function tests and lipid profile prior to treatment. - Monitoring: regularly assess psychiatric status and visual changes during therapy. - Concomitant vitamin A: avoid because of additive toxicity. - Women of child‑bearing potential: require effective contraception during treatment and for one month after discontinuation. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and light.

Isotretinoine Aurobindo can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of intracranial hypertension. - Vitamin A derivatives or supplements: additive teratogenic and toxic effects. - Systemic corticosteroids: may diminish isotretinoin efficacy.

Moderate Interactions (Monitor Closely): - Combined oral contraceptives: possible reduction in contraceptive effectiveness. - Anticoagulants (e.g., warfarin): potential alteration of INR values. - Lamotrigine: heightened risk of severe skin reactions. - Enzyme‑inducing agents (e.g., phenytoin, carbamazepine): may lower isotretinoin plasma concentrations.